INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $213,000 | -3.6% | 52,523 | 0.0% | 0.00% | – |
| Q4 2016 | $221,000 | -22.2% | 52,523 | +25.8% | 0.00% | – |
| Q3 2016 | $284,000 | +10.1% | 41,745 | -6.4% | 0.00% | – |
| Q2 2016 | $258,000 | -4.1% | 44,607 | +15.8% | 0.00% | – |
| Q1 2016 | $269,000 | -2.9% | 38,519 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $277,000 | -16.6% | 38,519 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $332,000 | -46.6% | 38,519 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $622,000 | – | 38,519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|